Gastrointestinal factors contribute to glucometabolic disturbances in nondiabetic patients with end-stage renal disease-Reference-Cited by-同舟云学术

Gastrointestinal factors contribute to glucometabolic disturbances in nondiabetic patients with end-stage renal disease

Published:2013-05 Issue:5 Volume:83 Page:915-923
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Idorn Thomas,Knop Filip K,Jørgensen Morten,Holst Jens J,Hornum Mads,Feldt-Rasmussen Bo

Publisher

Elsevier BV

Subject

Nephrology

Reference39 articles.

1. Glucose intolerance in uremic patients: the relative contributions of impaired beta-cell function and insulin resistance;Alvestrand;Clin Nephrol,1989

2. Hyperglucagonemia of renal failure;Bilbrey;J Clin Invest,1974

3. Pathogenesis of glucose intolerance in uremia;DeFronzo;Metabolism,1978

4. Pre-diabetes and arterial stiffness in uraemic patients;Hornum;Nephrol Dial Transplant,2010

5. Evidence for increased risk of prediabetes in the uremic patient;Eldin;Nephron Clin Pract,2008

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impaired incretin homeostasis in non-diabetic moderate-severe CKD;2023-12-18

2. Use of Glucose-Lowering Agents in Diabetes and CKD;Kidney International Reports;2022-12

3. Loss of the Incretin Effect in Type 2 Diabetes: A Systematic Review and Meta-analysis;The Journal of Clinical Endocrinology & Metabolism;2022-04-09

4. The association of glucagon with disease severity and progression in patients with autosomal dominant polycystic kidney disease: an observational cohort study;Clinical Kidney Journal;2021-07-06

5. No detectable effect of a type 2 diabetes-associated TCF7L2 genotype on the incretin effect;Endocrine Connections;2020-12